Lowest Price Guaranteed From USD 5,899
Published
September 2022
Pages
150
View Count
4148
Example Insights
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Report Description
The global nutrigenomics market is projected to grow from USD 0.64 billion in 2022 to USD 3 billion by 2035, exhibiting a CAGR of 13% during forecast period
Given the recent shift from the one-size-fits-all model to a more personalized mode of treatment, there has been a growing interest in identification and adoption of novel techniques. It is estimated that there are around 20,000 genes present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advances in DNA sequencing technologies have enabled significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Further, the success of the Human Genome Project, which mapped the whole human DNA, has paved a path for the novel concept of nutrigenomics, the science studying the relationship between human genome, nutrition and health. Presently, extensive studies are being conducted to understand the interaction between nutrients and gene expression at the molecular level to determine effect of a specific nutrient and dietary regime on the human health. Although the field of nutritional genomics is still in a nascent stage, it is a moving at a very fast-pace and is believed to have the potential to lay the foundation for personalized nutrition offerings. Further, the growing interest in nutrigenomics is supported by the rising awareness about the influence of diet on human health and its potential with respect to minimizing the risk of various diet-related diseases, including diabetes, cardiovascular disorders, chronic respiratory diseases and oncological disorders.
At present, more than 100 companies are engaged in providing various types of nutrigenomic tests / services, including those focused on nutritional deficiency, food intolerance / sensitivity, nutrient metabolism, disease risk assessment, diet customization, lifestyle management and weight management, worldwide. It is worth mentioning that there are several companies that provide nutrigenomic test offerings directly to consumer, through availability of online genetic test kits and at-home sample collection facilities. Moreover, this field is evolving continuously, as researchers and industry players alike aim to enhance the existing offerings. In this context, in the past 3 years, over 135 nutrigenomics focused research articles have been published, highlighting the active initiatives of researchers to illustrate the effect of nutrition on regulation of gene expression. At present, there are some ethical and regulatory challenges associated with nutrigenomics, including the potential misuse of personal data, as well as uncertainty related to genetic phenotypic predispositions, for conditions where no proven treatment exists. However, the benefits offered by nutrigenomics outweigh the uncertainty associated with its adoption. Considering the growing focus on personalized diets and active initiatives being undertaken by players in this domain, we are led to believe that the opportunity for stakeholders in this niche, but upcoming, industry is likely to grow at a commendable pace in the foreseen future.
The ‘Nutrigenomics Market: Distribution by Type of Sample (Saliva and Other Samples), Type of Sample Collection Method (At-home Sample Collection and Lab Sample Collection) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current landscape and future potential of the nutrigenomics focused companies. The study features an in-depth analysis, highlighting the capabilities of nutrigenomics focused companies. Amongst other elements, the report features:
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the nutrigenomics market, over the coming 13 years. We have provided informed estimates of the likely evolution of the nutrigenomics market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity within this domain have further been segmented based on relevant parameters, such as [A] type of sample (saliva and other samples), [B] type of sample collection method (at-home sample collection and lab sample collection) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and Rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:
Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Nutrigenomics
3.2.1. Tools for Nutrigenomics Testing
3.3. Applications of Nutrigenomics
3.4. Types of Nutrigenomics Companies
3.4.1. Traditional Nutrigenomics Companies
3.4.2. Direct-to-Consumer Nutrigenomics Companies
3.5. Challenges Associated with Nutrigenomics
3.6. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Nutrigenomics: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Type of Business Model
4.2.5. Analysis by Type of Genetic Test Offered
4.2.6. Analysis by Associated Service(s) Offered
4.2.7. Analysis by Type of Sample Analyzed
4.2.8. Analysis by Type of Sample Collection Method
4.2.9. Analysis by Mode of Communication
4.2.10. Analysis by Target Therapeutic Area
4.2.11. Key Players: Analysis by Number of Nutrigenomics Tests Offered
5. BENCHMARK ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Benchmark Analysis: Peer Groups
5.4.1. Benchmark Analysis for North America (Peer Group I)
5.4.2. Benchmark Analysis for Europe (Peer Group II)
5.4.3. Benchmark Analysis for Asia Pacific and Rest of the World (Peer Group III)
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. 3X4 Genetics
6.2.1. Company Overview
6.2.2. Nutrigenomics focused Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Advanced Nutrigenomics
6.3.1. Company Overview
6.3.2. Nutrigenomics focused Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. DNAlysis Biotechnology
6.4.1. Company Overview
6.4.2. Nutrigenomics focused Service Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. DNA Health and Wellness
6.5.1. Company Overview
6.5.2. Nutrigenomics focused Service Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Geno Palate
6.6.1. Company Overview
6.6.2. Nutrigenomics focused Service Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Mapymygenome
6.7.1. Company Overview
6.7.2. Nutrigenomics focused Service Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Nutrigenetix
6.8.1. Company Overview
6.8.2. Nutrigenomics focused Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Nutrigenomix
6.9.1. Company Overview
6.9.2. Nutrigenomics focused Service Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Vieroots
6.10.1. Company Overview
6.10.2. Nutrigenomics focused Service Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. Vitagenum
6.11.1. Company Overview
6.11.2. Nutrigenomics focused Service Portfolio
6.11.3. Recent Developments and Future Outlook
7. PUBLICATION ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Nutrigenomics: Publication Analysis
7.3.1. Analysis by Year of Publication
7.3.2. Analysis by Type of Publication
7.3.3. Most Popular Journals: Analysis by Number of Publications
7.3.4. Most Popular Journals: Analysis by Journal Impact Factor
7.3.5. Analysis by Popular Keywords
7.3.6. Most Active Publishers: Analysis by Number of Publications
7.3.7. Most Popular Affiliations: Analysis by Number of Publications
7.3.8. Analysis by Geography
8. PORTER’S FIVE FORCES ANALYSIS
8.1. Chapter Overview
8.2. Methodology and Assumptions
8.3. Key Parameters
8.3.1. Threat of New Entrants
8.3.2. Bargaining Power of Nutrigenomic Companies
8.3.3. Bargaining Power of Clients
8.3.4. Threat of Substitute Technologies
8.3.5. Rivalry Among Existing Competitors
8.4. Concluding Remarks
9. MARKET FORECAST AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Key Assumptions
9.3. Global Nutrigenomics Market, 2022-2035
9.3.1. Nutrigenomics Market: Distribution by Type of Sample Analyzed, 2022 and 2035
9.3.1.1. Nutrigenomics Market for Saliva Sample, 2022-2035
9.3.1.2. Nutrigenomics Market for Other Samples, 2022-2035
9.3.2. Nutrigenomics Market: Distribution by Type of Sample Collection Method, 2022 and 2035
9.3.2.1. Nutrigenomics Market for At-home Sample Collection, 2022-2035
9.3.2.2. Nutrigenomics Market for Lab Sample Collection, 2022-2035
9.3.2.3. Nutrigenomics Market for Both Type of Sample Collection Methods, 2022-2035
9.3.3. Nutrigenomics Market: Distribution by Geography, 2022 and 2035
9.3.3.1. Nutrigenomics Market in North America, 2022-2035
9.3.3.2. Nutrigenomics Market in Europe, 2022-2035
9.3.3.3. Nutrigenomics Market in Asia Pacific, 2022-2035
9.3.3.4. Nutrigenomics Market in Latin America, 2022-2035
9.3.3.5. Nutrigenomics Market in Middle East and North Africa, 2022-2035
9.3.3.6. Nutrigenomics Market in Rest of the World, 2022-2035
10. CONCLUDING REMARKS
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. DNApal.me
11.2.1. Company Snapshot
11.2.2. Interview Transcript: Kate Scott (Co-Founder)
11.3. GeneScope.ai HealthTech
11.3.1. Company Snapshot
11.3.2. Interview Transcript: Vishwajeet Jathar (Co-Founder)
11.4. Percent-Edge
11.4.1. Company Snapshot
11.4.2. Interview Transcript: Simon Bradley (Founder)
11.5. Vitagene / 1Health
11.5.1. Company Snapshot
11.5.2. Interview Transcript: Mehdi Maghsoodnia (Chief Executive Officer)
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Publication Analysis
Figure 2.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Overview of Nutrigenomics
Figure 3.2 Steps of Direct-to-Consumer Nutrigenomics Testing
Figure 3.3 Applications of Nutrigenomics
Figure 4.1 Nutrigenomics: Distribution by Year of Establishment
Figure 4.2 Nutrigenomics: Distribution by Company Size
Figure 4.3 Nutrigenomics: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Nutrigenomics: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Nutrigenomics: Distribution by Company Size and Location of Headquarters
Figure 4.6 Nutrigenomics: Distribution by Type of Business Model
Figure 4.7 Nutrigenomics: Distribution by Type of Genetic Test Offered
Figure 4.8 Nutrigenomics: Distribution by Associated Service(s) Offered
Figure 4.9 Nutrigenomics: Distribution by Type of Sample Analyzed
Figure 4.10 Nutrigenomics: Distribution by Type of Sample Collection Method
Figure 4.11 Nutrigenomics: Distribution by Mode of Communication
Figure 4.12 Nutrigenomics: Distribution by Target Therapeutic Area
Figure 4.13 Key Players: Distribution by Number of Nutrigenomics Tests Offered
Figure 5.1 Company Competitiveness: North America (Peer Group I)
Figure 5.2 Benchmark Analysis for North America (Peer Group I)
Figure 5.3 Company Competitiveness: Europe (Peer Group II)
Figure 5.4 Benchmark Analysis for Europe (Peer Group II)
Figure 5.5 Company Competitiveness: Asia-Pacific and Rest of the World (Peer Group III)
Figure 5.6 Benchmark Analysis for Asia-Pacific and Rest of the World (Peer Group III)
Figure 7.1 Publication Analysis: Distribution by Year of Publication
Figure 7.2 Publication Analysis: Distribution by Type of Publication
Figure 7.3 Most Popular Journals: Distribution by Number of Publications
Figure 7.4 Most Popular Journals: Distribution by Journal Impact Factor
Figure 7.5 Publication Analysis: Most Popular Keywords
Figure 7.6 Most Active Publisher: Distribution by Number of Publications
Figure 7.7 Most Popular Affiliation: Distribution by Number of Publications
Figure 7.8 Publication Analysis: Distribution by Geography
Figure 8.1 Porter’s Five Forces: Key Parameters
Figure 8.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 9.1 Global Nutrigenomics Market, 2022-2035 (USD Billion)
Figure 9.2 Nutrigenomics Market: Likely Growth Scenarios
Figure 9.3 Nutrigenomics Market: Distribution by Type of Sample Analyzed, 2022 and 2035 (USD Billion)
Figure 9.4 Nutrigenomics Market for Saliva Sample, 2022-2035 (USD Billion)
Figure 9.5 Nutrigenomics Market for Other Samples, 2022-2035 (USD Billion)
Figure 9.6 Nutrigenomics Market: Distribution by Type of Sample Collection Method, 2022 and 2035 (USD Billion)
Figure 9.7 Nutrigenomics Market for At-home Sample Collection, 2022-2035 (USD Billion)
Figure 9.8 Nutrigenomics Market for Lab Sample Collection, 2022-2035 (USD Billion)
Figure 9.9 Nutrigenomics Market for Both Type of Sample Collection Methods, 2022-2035 (USD Billion)
Figure 9.10 Nutrigenomics Market: Distribution by Geography, 2022 and 2035 (USD Billion)
Figure 9.11 Nutrigenomics Market in North America, 2022-2035 (USD Billion)
Figure 9.12 Nutrigenomics Market in Europe, 2022-2035
Figure 9.13 Nutrigenomics Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 9.14 Nutrigenomics Market in Latin America, 2022-2035 (USD Billion)
Figure 9.15 Nutrigenomics Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 9.16 Nutrigenomics Market in Rest of the World, 2022-2035 (USD Billion)
Figure 10.1 Concluding Remarks: Market Landscape
Figure 10.2 Concluding Remarks: Benchmark Analysis
Figure 10.3 Concluding Remarks: Publication Analysis
Figure 10.4 Concluding Remarks: Porter’s Five Forces
Figure 10.6 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Nutrigenomics Companies: Information on Year of Establishment, Company Size, Location of Headquarters, Type of Business Model and Nutrigenomics Tests Offered
Table 4.2 Nutrigenomics Companies: Information on Type of Genetic Tests and Associated Services Offered
Table 4.3 Nutrigenomics Companies: Information on Type of Sample Analyzed and Type of Sample Collection Method
Table 4.4 Nutrigenomics Companies: Information on Mode of Communication and Target Therapeutic Area
Table 5.1 Benchmark Analysis: Information on Peer Groups
Table 6.1 3X4 Genetics: Company Snapshot
Table 6.2 3X4 Genetics: Nutrigenomics focused Service Portfolio
Table 6.3 Advanced Nutrigenomics: Company Snapshot
Table 6.4 Advanced Nutrigenomics: Nutrigenomics focused Service Portfolio
Table 6.5 DNALysis Biotechnology: Company Snapshot
Table 6.6 DNALysis Biotechnology: Nutrigenomics focused Service Portfolio
Table 6.7 DNALysis Biotechnology: Recent Developments and Future Outlook
Table 6.8 DNA Health and Wellness: Company Snapshot
Table 6.9 DNA Health and Wellness: Nutrigenomics focused Service Portfolio
Table 6.10 GenoPalate: Company Snapshot
Table 6.11 GenoPalate: Nutrigenomics focused Service Portfolio
Table 6.12 GenoPalate: Recent Developments and Future Outlook
Table 6.13 Mapmygenome: Company Snapshot
Table 6.14 Mapmygenome: Nutrigenomics focused Service Portfolio
Table 6.15 Nutrigenetix: Company Snapshot
Table 6.16 Nutrigenetix: Nutrigenomics focused Service Portfolio
Table 6.17 Nutrigenetix: Recent Developments and Future Outlook
Table 6.18 Nutrigenomix: Company Snapshot
Table 6.19 Nutrigenomix: Nutrigenomics focused Service Portfolio
Table 6.20 Vieroots: Company Snapshot
Table 6.21 Vieroots: Nutrigenomics focused Service Portfolio
Table 6.22 Vitagenum: Company Snapshot
Table 6.23 Vitagenum: Nutrigenomics focused Service Portfolio
Table 7.1 Nutrigenomics: List of Recent Publications, 2019-2022
Table 11.1 DNApal.me: Company Snapshot
Table 11.2 GeneScope HealthTech: Company Snapshot
Table 11.3 Percent-Edge: Company Snapshot
Table 11.4 Vitagene: Company Snapshot
Table 12.1 Nutrigenomics: Distribution by Year of Establishment
Table 12.2 Nutrigenomics: Distribution by Company Size
Table 12.3 Nutrigenomics: Distribution by Location of Headquarters (Region-wise)
Table 12.4 Nutrigenomics: Distribution by Location of Headquarters (Country-wise)
Table 12.5 Nutrigenomics: Distribution by Company Size and Location of Headquarters
Table 12.6 Nutrigenomics: Distribution by Type of Business Model
Table 12.7 Nutrigenomics: Distribution by Type of Genetic Test Offered
Table 12.8 Nutrigenomics: Distribution by Associated Service(s) Offered
Table 12.9 Nutrigenomics: Distribution by Type of Sample Analyzed
Table 12.10 Nutrigenomics: Distribution by Type of Sample Collection Method
Table 12.11 Nutrigenomics: Distribution by Mode of Communication
Table 12.12 Nutrigenomics: Distribution by Target Therapeutic Area
Table 12.13 Key Players: Distribution by Number of Nutrigenomics Tests Offered
Table 12.14 Publication Analysis: Distribution by Year of Publication
Table 12.15 Publication Analysis: Distribution by Type of Publication
Table 12.16 Most Popular Journals: Distribution by Number of Publications
Table 12.17 Most Popular Journals: Distribution by Journal Impact Factor
Table 12.18 Publication Analysis: Most Popular Keywords
Table 12.19 Most Active Publisher: Distribution by Number of Publications
Table 12.20 Most Popular Affiliation: Distribution by Number of Publications
Table 12.21 Publication Analysis: Distribution by Geography
Table 12.22 Global Nutrigenomics Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.23 Nutrigenomics Market: Distribution by Type of Sample Analyzed, 2022 and 2035 (USD Billion)
Table 12.24 Nutrigenomics Market for Saliva Sample, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.25 Nutrigenomics Market for Other Samples, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.26 Nutrigenomics Market: Distribution by Type of Sample Collection Method, 2022 and 2035 (USD Billion)
Table 12.27 Nutrigenomics Market for At-home Sample Collection, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.28 Nutrigenomics Market for Lab Sample Collection, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.29 Nutrigenomics Market for Both Type of Sample Collection Methods, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.30 Nutrigenomics Market: Distribution by Geography, 2022 and 2035 (USD Billion)
Table 12.31 Nutrigenomics Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.32 Nutrigenomics Market in Europe, Conservative, Base and Optimistic Scenarios, 2022 and 2035
Table 12.33 Nutrigenomics Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.34 Nutrigenomics Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.35 Nutrigenomics Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 12.36 Nutrigenomics Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
The following companies / institutes / government bodies and organizations have been mentioned in this report.